A study to assess the pharmacokinetics of ceftaroline in end stage renal disease patients and matched healthy subjects

Exclusion Criteria

• - History or presence of gastrointestinal, hepatic, or any other condition known to interfere with the absorption, distribution, metabolism, or excretion of drugs
• - Any clinically significant abnormalities in clinical chemistry, haematology, or urinalysis results, as judged by the investigator
• - Any clinically important abnormalities in rhythm, conduction, or morphology of resting ECG that may interfere with the interpretation of QTc interval changes
• - History of any clinically significant disease or disorder which, in the opinion of the investigator, may either put the subject at risk because of participation in the study, or influence the results or the subject's ability to participate in the study
• - Receiving any dialysis treatment other than intermittent haemodialysis